Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Free Cash Flow (2021 - 2025)

Historic Free Cash Flow for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to -$3.8 million.

  • Biofrontera's Free Cash Flow fell 20270.92% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.0 million, marking a year-over-year increase of 3431.25%. This contributed to the annual value of -$10.3 million for FY2024, which is 5860.27% up from last year.
  • Biofrontera's Free Cash Flow amounted to -$3.8 million in Q3 2025, which was down 20270.92% from -$3.1 million recorded in Q2 2025.
  • Biofrontera's Free Cash Flow's 5-year high stood at $81000.0 during Q2 2022, with a 5-year trough of -$21.0 million in Q4 2021.
  • For the 5-year period, Biofrontera's Free Cash Flow averaged around -$4.7 million, with its median value being -$3.4 million (2021).
  • Its Free Cash Flow has fluctuated over the past 5 years, first surged by 10760.56% in 2022, then plummeted by 1284691.36% in 2023.
  • Over the past 5 years, Biofrontera's Free Cash Flow (Quarter) stood at -$21.0 million in 2021, then skyrocketed by 60.6% to -$8.3 million in 2022, then dropped by 7.12% to -$8.9 million in 2023, then surged by 89.17% to -$960000.0 in 2024, then plummeted by 295.73% to -$3.8 million in 2025.
  • Its last three reported values are -$3.8 million in Q3 2025, -$3.1 million for Q2 2025, and -$4.1 million during Q1 2025.